Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.88 - $2.19 $8.36 Million - $20.8 Million
9,503,782 New
9,503,782 $10.1 Million
Q2 2022

Aug 15, 2022

SELL
$1.15 - $2.53 $911,430 - $2.01 Million
-792,548 Reduced 12.4%
5,598,807 $7.5 Million
Q1 2022

May 16, 2022

SELL
$1.91 - $3.98 $81,333 - $169,480
-42,583 Reduced 0.66%
6,391,355 $13.5 Million
Q4 2021

Feb 14, 2022

SELL
$3.53 - $5.5 $5.74 Million - $8.94 Million
-1,625,183 Reduced 20.17%
6,433,938 $23.9 Million
Q3 2021

Nov 15, 2021

SELL
$4.99 - $6.55 $5.98 Million - $7.85 Million
-1,198,747 Reduced 12.95%
8,059,121 $40.2 Million
Q2 2021

Aug 16, 2021

BUY
$6.24 - $8.22 $975,892 - $1.29 Million
156,393 Added 1.72%
9,257,868 $60.4 Million
Q1 2021

May 17, 2021

BUY
$6.74 - $10.95 $13.3 Million - $21.5 Million
1,967,381 Added 27.58%
9,101,475 $62.7 Million
Q4 2020

Feb 16, 2021

SELL
$3.75 - $10.56 $1.59 Million - $4.48 Million
-424,482 Reduced 5.62%
7,134,094 $72.8 Million
Q3 2020

Nov 16, 2020

SELL
$3.5 - $6.2 $579,806 - $1.03 Million
-165,659 Reduced 2.14%
7,558,576 $26.5 Million
Q2 2020

Aug 14, 2020

BUY
$2.16 - $5.46 $596,695 - $1.51 Million
276,248 Added 3.71%
7,724,235 $38.5 Million
Q1 2020

May 15, 2020

BUY
$1.46 - $7.19 $10.9 Million - $53.6 Million
7,447,987 New
7,447,987 $25.3 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $281M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track Bill Miller's Portfolio

Track Bill Miller Portfolio

Follow Bill Miller (Miller Value Partners, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.